A prospective study comparing celecoxib with naproxen in children with juvenile rheumatoid arthritis

Journal of Rheumatology

Volumn 36, Issue 1, 2009, Pages 174-182

  Foeldvari, Ivan ^a,f   Szer, Ilona S ^b   Zemel, Lawrence S ^c   Lovell, Daniel J ^d   Giannini, Edward H ^d   Robbins, Jeffery L ^e   West, Christine R ^e   Steidle, Gina ^e   Krishnaswami, Sriram ^e   Bloom, Bradley J ^e  

^a Hamburger Zentrum fur Kinder und Jugendrheumatologie   (Germany)

^b RADY CHILDREN'S HOSPITAL   (United States)

^c Farmington   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^e PFIZER INC   (United States)

^f Kinder und Jugendrheumatologe   (Germany)

Author keywords

American College of Rheumatology criteria; Celecoxib; Juvenile rheumatoid arthritis; Naproxen

Indexed keywords

CELECOXIB; NAPROXEN;

ABDOMINAL PAIN; ADOLESCENT; ARTHRALGIA; ARTICLE; ASTHMA; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; CYTOMEGALOVIRUS INFECTION; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EPIGASTRIC PAIN; EYE DISEASE; FEMALE; FEVER; GENERAL CONDITION IMPROVEMENT; HEADACHE; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PERICARDITIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; SCHOOL CHILD; SKIN DISEASE; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; VIRUS INFECTION; VOMITING;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; NAPROXEN; PROSPECTIVE STUDIES; PYRAZOLES; SULFONAMIDES; TREATMENT OUTCOME;

EID: 58149517573     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.080073     Document Type: Article

References (33)

1. Lahdenne P, Vahasalo P, Honkanen V. Infliximab or etanercept in the treatment of children with refractory juvenile idiopathic arthritis: an open label study. Ann Rheum Dis 2003;62:245-7.
2. Schanberg LE, Anthony KK, Gil KM, Maurin EC. Daily pain and symptoms in children with polyarticular arthritis. Arthritis Rheum 2003;48:1390-7.
3. Cron RQ, Sharma S, Sherry DD. Current treatment by United States and Canadian pediatric rheumatologists. J Rheumatol 1999;26:2036-8.
4. Ruperto N, Nikishina I, Pachanov ED, et al. A randomized, double-blind clinical trial of two doses of meloxicam compared with naproxen in children with juvenile idiopathic arthritis: short- and long-term efficacy and safety results. Arthritis Rheum 2005;52:563-72.
5. Allison MC, Howatson AG, Torrance CJ, Lee FD, Russell RI. Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. N Engl J Med 1992;327:749-54.
6. Moore RA, Derry S, Makinson GT, McQuay HJ. Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: systematic review and meta-analysis of information from company clinical trial reports. Arthritis Res Ther 2005;7:R644-65.
7. Cassidy JT. Medical management of children with juvenile rheumatoid arthritis. Drugs 1999;58:831-50.
8. Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 1997;40:1202-9.
9. Reiff A, Lovell DJ, Adelsberg JV, et al. Evaluation of the comparative efficacy and tolerability of rofecoxib and naproxen in children and adolescents with juvenile rheumatoid arthritis: a 12-week randomized controlled clinical trial with a 52-week open-label extension. J Rheumatol 2006;33:985-95.
10. Gedalia A, Espada G, Johnson P, Kovacs B, Wood C, Padula S. Meloxicam in JRA Study Group. Efficacy and safety of meloxicam oral suspension in the treatment of juvenile rheumatoid arthritis (JRA): results from a twelve-week active-controlled (naproxen oral suspension), multinational trial [abstract]. Arthritis Rheum 2004;50 Suppl:S95.
11. Laxer RM, Silverman ED, St. Cyr C, Tran MT, Lingam G. A six-month open safety assessment of a naproxen suspension formulation in the therapy of juvenile rheumatoid arthritis. Clin Ther 1988;10:381-7.
12. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004;114 Suppl 2:1-22.
13. Kvien TK, Hoyeraal HM, Sandstad B. Naproxen and acetylsalicylic acid in the treatment of pauciarticular and polyarticular juvenile rheumatoid arthritis. Assessment of tolerance and efficacy in a single-centre 24-week double-blind parallel study. Scand J Rheumatol 1984;13:342-50.
14. Leak AM, Richter MR, Clemens LE, Hall MA, Ansell BM. A crossover study of naproxen, diclofenac and tolmetin in seronegative juvenile chronic arthritis. Clin Exp Rheumatol 1988;6:157-60.
15. Giannini EH, Brewer EJ, Miller ML, et al. Ibuprofen suspension in the treatment of juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. J Pediatr 1990;117:645-52.
16. Goodman S, Howard P, Haig A, Flavin S, MacDonald B. An open label study to establish dosing recommendations for nabumetone in juvenile rheumatoid arthritis. J Rheumatol 2003;30:829-31.
17. Levinson JE, Baum J, Brewer E Jr, Fink C, Hanson V, Schaller J. Comparison of tolmetin sodium and aspirin in the treatment of juvenile rheumatoid arthritis. J Pediatr 1977;91:799-804.
18. Moran H, Hanna DB, Ansell BM, Hall M, Engler C. Naproxen in juvenile chronic polyarthritis. Ann Rheum Dis 1979;38:152-4.
19. Bass J, Athreya B, Brandstrup N, et al. Flurbiprofen in the treatment of juvenile rheumatoid arthritis. J Rheumatol 1986;13:1081-3.
20. Bass JC, Athreya BH, Brewer EJ, et al. A once-daily antiinflammatory drug, oxaprozin, in the treatment of juvenile rheumatoid arthritis. The Pediatric Rheumatology Collaborative Study Group. J Rheumatol 1985;12:384-6.
21. Bhettay E, Thomson AJ. Double-blind study of ketoprofen and indomethacin in juvenile chronic arthritis. S Afr Med J 1978;54:276-8.
22. Haapasaari J, Wuolijoki E, Ylijoki H. Treatment of juvenile rheumatoid arthritis with diclofenac sodium. Scand J Rheumatol 1983;12:325-30.
23. Williams PL, Ansell BM, Bell A, et al. Multicentre study of piroxicam versus naproxen in juvenile chronic arthritis, with special reference to problem areas in clinical trials of nonsteroidal anti-inflammatory drugs in childhood. Br J Rheumatol 1986;25:67-71.
24. DeWitt EM, Sherry DD, Cron RQ. Pediatric rheumatology for the adult rheumatologist. I: Therapy and dosing for pediatric rheumatic disorders. J Clin Rheumatol 2005;11:21-33.
25. Keenan GF, Giannini EH, Athreya BH. Clinically significant gastropathy associated with nonsteroidal antiinflammatory drug use in children with juvenile rheumatoid arthritis. J Rheumatol 1995;22:1149-51.
26. Mulberg AE, Linz C, Bern E, Tucker L, Verhave M, Grand RJ. Identification of nonsteroidal antiinflammatory drug-induced gastroduodenal injury in children with juvenile rheumatoid arthritis. J Pediatr 1993;122:647-9.
27. Hermaszewski R, Hayllar J, Woo P. Gastro-duodenal damage due to non-steroidal anti-inflammatory drugs in children. Br J Rheumatol 1993;32:69-72.
28. Dowd JE, Cimaz R, Fink CW. Nonsteroidal antiinflammatory drug-induced gastroduodenal injury in children. Arthritis Rheum 1995;38:1225-31.
29. Menniti-Ippolito F, Traversa G, Da Cas R. Gastroduodenal adverse reactions to drugs in children in Italy [abstract]. Pharmacoepidemiol Drug Saf 2004;13:S141.
30. Bertagnolli MM, Eagle CJ, Zauber AG, et al. Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med 2006;355:873-84.
31. Muntner P, He J, Cutler JA, Wildman RP, Whelton PK. Trends in blood pressure among children and adolescents. JAMA 2004;291:2107-13.
32. Juonala M, Jarvisalo MJ, Maki-Torkko N, Kahonen M, Viikari JS, Raitakari OT. Risk factors identified in childhood and decreased carotid artery elasticity in adulthood: the Cardiovascular Risk in Young Finns Study. Circulation 2005;112:1486-93.
33. Cassidy JT, Petty RE. Textbook of pediatric rheumatology. 5th ed. Philadelphia: W.B. Saunders; 2005.